We examine the issues and actors that have shaped the agenda of shareholder activism on global social issues over the last 35 years. Our analysis of 2158 US shareholders’ proposals on the topics of international human rights and labor standards reveals that a clear agenda has developed, dominated by religious organizations that have sponsored or co-sponsored 1312 of these proposals. Public pension funds entered the field of global social issue activism after religious organizations had already established the legitimacy of the agenda. We suggest that a social movement perspective on shareholder activism best explains these findings. Religious groups framed the ideas that constitute the global social issues shareholder agenda and mobilized support by reaching out to other types of investors. Public pension funds played a secondary, albeit important, role in agenda creation by championing several of the campaigns initiated by religious innovators.
Evaluation of negotiation outcomes tends to focus on measurable, dyadic, short‐term resolutions of conflict. We review current challenges to this traditional model of the evaluation of dispute resolution outcomes, and we offer four perspectives that can help address them. First, we advocate the need for longitudinal studies of negotiations that incorporate disputant relationships before and after a particular negotiation. Second, we highlight the increasing importance of third parties in resolving conflict. Third, we suggest a more comprehensive conception of parties, relationships and outcomes in negotiations research. Finally, we advance an explicit incorporation of context and culture into dispute resolution research models.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.